Duopharma Biotech Bhd. Stock Analysis DPHARMA.KL

Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor and currently employs 1,957 full-time employees. The company went IPO on 2002-07-18. The firm is engaged in the manufacture and distribution of pharmaceutical products. Its Consumer Healthcare (CHC) business is responsible for the marketing and distribution of over-the-counter products, including vitamins, minerals and supplements and cosmeceuticals in the domestic and regional markets. Its Ethical Classic Business is involved in the manufacture, distribution and sales of drugs that treat a wide range of ailments, from cardiovascular, dermatological and hormonal conditions to respiratory, sensory, nervous and musculoskeletal system diseases, among others. Its Ethical Specialty Business focuses on treatments, including generics and biosimilars-that target its three specialty (or franchise) areas, namely kidney disease, cancer and diabetes. The company has core competencies in the pharmaceutical industry inclusive of manufacturing, research and development and commercialization and marketing of over 300 generic drugs.